Does IXABEPILONE Cause Malignant neoplasm progression? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Malignant neoplasm progression have been filed in association with IXABEPILONE (IXEMPRA). This represents 7.1% of all adverse event reports for IXABEPILONE.
26
Reports of Malignant neoplasm progression with IXABEPILONE
7.1%
of all IXABEPILONE reports
9
Deaths
3
Hospitalizations
How Dangerous Is Malignant neoplasm progression From IXABEPILONE?
Of the 26 reports, 9 (34.6%) resulted in death, 3 (11.5%) required hospitalization, and 1 (3.8%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IXABEPILONE. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does IXABEPILONE Cause?
Anaemia (55)
Death (49)
Neutrophil count decreased (48)
White blood cell count decreased (45)
Pseudocirrhosis (31)
Fatigue (30)
Vomiting (30)
Nausea (25)
Platelet count decreased (25)
Portal hypertension (23)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which IXABEPILONE Alternatives Have Lower Malignant neoplasm progression Risk?
IXABEPILONE vs IXAZOMIB
IXABEPILONE vs IXEKIZUMAB
IXABEPILONE vs JAKAFI
IXABEPILONE vs JANUMET
IXABEPILONE vs JANUVIA